ID: ALA3764641

Max Phase: Preclinical

Molecular Formula: C33H36N4O4S2

Molecular Weight: 616.81

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN1CCN(CCCOc2ccc(N3C(=O)/C(=C/c4ccc(Oc5ccc(C(=O)N(C)C)cc5)cc4)SC3=S)cc2)CC1

Standard InChI:  InChI=1S/C33H36N4O4S2/c1-34(2)31(38)25-7-13-29(14-8-25)41-28-11-5-24(6-12-28)23-30-32(39)37(33(42)43-30)26-9-15-27(16-10-26)40-22-4-17-36-20-18-35(3)19-21-36/h5-16,23H,4,17-22H2,1-3H3/b30-23-

Standard InChI Key:  VNQDDDXWQSBTRK-WMMMYUQOSA-N

Associated Targets(Human)

Inhibitor of nuclear factor kappa B kinase beta subunit 5554 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Inhibitor of nuclear factor kappa-B kinase subunit beta 81 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 616.81Molecular Weight (Monoisotopic): 616.2178AlogP: 5.60#Rotatable Bonds: 10
Polar Surface Area: 65.56Molecular Species: NEUTRALHBA: 8HBD: 0
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 0#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 8.11CX LogP: 5.19CX LogD: 4.40
Aromatic Rings: 3Heavy Atoms: 43QED Weighted: 0.17Np Likeness Score: -1.60

References

1. Kim D, Kim YG, Seo JH, Shin KJ..  (2016)  Identification and characterization of potent, selective and metabolically stable IKKβ inhibitor.,  26  (4): [PMID:26826731] [10.1016/j.bmcl.2016.01.065]

Source